Search

Author/Creator Svane, Inge M.

2. Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor‐induced colitis—authors' reply. Issue 1 (5th December 2022)

Authors:
Dahl, Emilie K.; Abed, Osama K.; Kjeldsen, Jens; Donia, Marco; Svane, Inge M.; Dige, Anders; Agnholt, Jørgen S.; Bjerrum, Jacob T.; Seidelin, Jakob B.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 57:Issue 1(2023)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R). (February 2023)

Authors:
Chen, Inna M.; Donia, Marco; Chamberlain, Christopher A.; Jensen, Agnete W.P.; Draghi, Arianna; Theile, Susann; Madsen, Kasper; Hasselby, Jane P.; Toxværd, Anders; Høgdall, Estrid; Lorentzen, Torben; Wilken, Eva E.; Geertsen, Poul; Svane, Inge M.; Johansen, Julia S.; Nielsen, Dorte
Journal:
European journal of cancer
Issue:
Volume 180(2023)
Page Start:
125
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗